Lymphangioma pathophysiology

Lymphangioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphangioma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lymphangioma pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lymphangioma pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lymphangioma pathophysiology
CDC on Lymphangioma pathophysiology
Lymphangioma pathophysiology in the news
Blogs on Lymphangioma pathophysiology
Directions to Hospitals Treating Lymphangioma
Risk calculators and risk factors for Lymphangioma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Pathogenesis

• Lymphangioma arises from lymphatic vessels, which are a vital part of the circulatory and immune system, where they are normally involved in re-circulation of excess body fluid back into the blood stream.
• Lymphangioma is a common benign tumor that often grows proportionally to the patients body growth rate.
• The exact pathogenesis of lymphangioma is not fully understood. It is thought that lymphangioma is caused by either sequestration of lymph tissue, abnormal budding of lymph vessels, lack of fusion with the venous system, or obstruction of lymph vessels.
• The progression to lymphangioma usually involves the following growth factors:

• VEGF-C
• VEGFR-3
• Prox-1
• bFGF
• PEDF
• Thrombospondin
• Reelin
• cMAF
• Integrin-α1, -α9

• Lymphangiomas most commonly develop at the head and neck regions.
• However, lymphangioma may also develop in other anatomical sites such as:

• Breast
• Upper and lower limbs
• Internal viscera

Associated Conditions

• Lymphangioma is associated with a number of conditions that include:

• Turner syndrome

Microscopic Pathology

• On microscopic histopathological analysis, characteristic findings of lymphangioma include:

• Thin walled channels lined by endothelium
• Intraluminal accumulation of eosinophilic deposits
• Clusters of intraluminal lymphocytes

• On immunohistochemistry, characteristic findings of lymphangioma include:

• D2-40 +ve

References

Template:WikiDoc Sources